Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kathleen Mellars"'
Autor:
Alex C Cheng, Rhonda Facile, John Owen, Richard Marshall, Kathleen Mellars, Nan Kennedy, Brenda Minor, Kyle McGuffin, Paul Harris
Publikováno v:
Journal of the Society for Clinical Data Management. 2
Introduction: A guiding principle behind the development and deployment of the REDCap data management platform has always included attention to workflow design that allows easy implementation of best practices for clinical and translational researche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76df1149416076fde0f1927be20a58ef
https://doi.org/10.47912/jscdm.172
https://doi.org/10.47912/jscdm.172
Autor:
Kathleen Mellars, Joseph F. Simeone, Allan Lipton, John J. Seaman, Gabriel N. Hortobagyi, Dirk J. Reitsma, Robert Knight, Richard L. Theriault, Maika Heffernan
Publikováno v:
Cancer. 88:1082-1090
BACKGROUND Pamidronate therapy previously has been shown to reduce skeletal complications effectively for up to 12 months in breast carcinoma patients with bone metastases. The current study data provide further follow-up results regarding the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8527d27e2ca82f01793003dc69bd6f67
https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co
https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co
Autor:
Joseph F. Simeone, Clive Sinoff, Maika Heffernan, Gabriel N. Hortobagyi, Kathleen Mellars, Douglas W. Blayney, Allan Lipton, Ian Kennedy, Simon G. Allan, Helen Wheeler, John J. Seaman, Lester Porter, Robert Knight, R. L. Theriault, Dirk J. Reitsma
Publikováno v:
New England Journal of Medicine. 335:1785-1792
Background Bisphosphonates such as pamidronate disodium inhibit osteoclast-induced bone resorption associated with cancer that has metastasized to bone. Methods Women with stage IV breast cancer who were receiving cytotoxic chemotherapy and had at le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6adea70ecd21819d5a2f9262ed55c02b
https://doi.org/10.1056/nejm199612123352401
https://doi.org/10.1056/nejm199612123352401
Autor:
Florence F Vickers, Kathleen Mellars, Scott A Strelow, Mark B. Sherwood, John Guy, Alison Napier, William T. Driebe, Lorraine J B Broncato
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 23:170-175
Ninety-two nonglaucomatous patients undergoing extracapsular cataract extraction with implantation of a posterior chamber intraocular lens by residents at a Veterans hospital were randomized in double-masked fashion to receive either a topical nonste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e84a5fcfa516a51e9cb6a244880178a6
https://doi.org/10.3928/1542-8877-19920301-07
https://doi.org/10.3928/1542-8877-19920301-07
Autor:
Kathleen Mellars, John J. Seaman, Maika Heffernan, Lester Porter, Dirk J. Reitsma, Clive Sinoff, Robert Knight, Douglas W. Blayney, Allan Lipton, Joseph F. Simeone, Helen Wheeler, R. L. Theriault, Gabriel N. Hortobagyi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 16(6)
PURPOSE Pamidronate, an aminobisphosphonate, has been shown to lower the risk of skeletal complications associated with lytic bone lesions for up to 1 year in women with stage IV breast cancer who received chemotherapy. We studied the long-term effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e186e088e27f760d7c61f533fba892
https://pubmed.ncbi.nlm.nih.gov/9626201
https://pubmed.ncbi.nlm.nih.gov/9626201
Autor:
Kathleen Mellars, Stefan Glück, John F. Stewart, Dirk J. Reitsma, Gabriel N. Hortobagyi, Allan Lipton, Robert Knight, Ian Kennedy, Maika Heffernan, Richard Leff, Sean Costello, Joseph F. Simeone, John J. Seaman, Richard L. Theriault
Publikováno v:
Journal of Clinical Oncology. 17:846-846
PURPOSE: To assess whether pamidronate can reduce the frequency of skeletal morbidity in women with lytic bone metastases from breast cancer treated with hormone therapy. PATIENTS AND METHODS: Three hundred seventy-two women with breast cancer who ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b5052a5c9aa4454287bdcf9f81d0a1
https://doi.org/10.1200/jco.1999.17.3.846
https://doi.org/10.1200/jco.1999.17.3.846